606 related articles for article (PubMed ID: 27613129)
21. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
[TBL] [Abstract][Full Text] [Related]
22. The role of RNA processing and regulation in metastatic dormancy.
Parker KA; Robinson NJ; Schiemann WP
Semin Cancer Biol; 2022 Jan; 78():23-34. PubMed ID: 33775829
[TBL] [Abstract][Full Text] [Related]
23. Label retaining cells in cancer--the dormant root of evil?
Schillert A; Trumpp A; Sprick MR
Cancer Lett; 2013 Nov; 341(1):73-9. PubMed ID: 23624300
[TBL] [Abstract][Full Text] [Related]
24. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
25. Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes.
Jahangiri L; Ishola T
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563661
[TBL] [Abstract][Full Text] [Related]
26. Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening.
Sistigu A; Musella M; Galassi C; Vitale I; De Maria R
Front Immunol; 2020; 11():2166. PubMed ID: 33193295
[TBL] [Abstract][Full Text] [Related]
27. Minimal Residual Disease, Metastasis and Immunity.
Badia-Ramentol J; Linares J; Gómez-Llonin A; Calon A
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33498251
[TBL] [Abstract][Full Text] [Related]
28. Tumor dormancy: long-term survival in a hostile environment.
Quesnel B
Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
[TBL] [Abstract][Full Text] [Related]
29. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.
Correia AL; Guimaraes JC; Auf der Maur P; De Silva D; Trefny MP; Okamoto R; Bruno S; Schmidt A; Mertz K; Volkmann K; Terracciano L; Zippelius A; Vetter M; Kurzeder C; Weber WP; Bentires-Alj M
Nature; 2021 Jun; 594(7864):566-571. PubMed ID: 34079127
[TBL] [Abstract][Full Text] [Related]
30. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
31. Connecting cancer relapse with senescence.
Pluquet O; Abbadie C; Coqueret O
Cancer Lett; 2019 Oct; 463():50-58. PubMed ID: 31404612
[TBL] [Abstract][Full Text] [Related]
32. Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy.
Qin S; Li B; Ming H; Nice EC; Zou B; Huang C
Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188749. PubMed ID: 35716972
[TBL] [Abstract][Full Text] [Related]
33. Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse.
Muzes G; Sipos F
Anticancer Agents Med Chem; 2017; 17(4):472-482. PubMed ID: 27592547
[TBL] [Abstract][Full Text] [Related]
34. Cancer dormancy: a model of early dissemination and late cancer recurrence.
Páez D; Labonte MJ; Bohanes P; Zhang W; Benhanim L; Ning Y; Wakatsuki T; Loupakis F; Lenz HJ
Clin Cancer Res; 2012 Feb; 18(3):645-53. PubMed ID: 22156560
[TBL] [Abstract][Full Text] [Related]
35. ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.
Sosa MS; Avivar-Valderas A; Bragado P; Wen HC; Aguirre-Ghiso JA
Clin Cancer Res; 2011 Sep; 17(18):5850-7. PubMed ID: 21673068
[TBL] [Abstract][Full Text] [Related]
36. The biology and clinical implications of prostate cancer dormancy and metastasis.
Morrissey C; Vessella RL; Lange PH; Lam HM
J Mol Med (Berl); 2016 Mar; 94(3):259-65. PubMed ID: 26489605
[TBL] [Abstract][Full Text] [Related]
37. Tumor cell dormancy.
Gomis RR; Gawrzak S
Mol Oncol; 2017 Jan; 11(1):62-78. PubMed ID: 28017284
[TBL] [Abstract][Full Text] [Related]
38. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.
Rossari F; Zucchinetti C; Buda G; Orciuolo E
Cell Oncol (Dordr); 2020 Apr; 43(2):155-176. PubMed ID: 31392521
[TBL] [Abstract][Full Text] [Related]
39. Redox Control of the Dormant Cancer Cell Life Cycle.
Li B; Huang Y; Ming H; Nice EC; Xuan R; Huang C
Cells; 2021 Oct; 10(10):. PubMed ID: 34685686
[TBL] [Abstract][Full Text] [Related]
40. The perivascular niche regulates breast tumour dormancy.
Ghajar CM; Peinado H; Mori H; Matei IR; Evason KJ; Brazier H; Almeida D; Koller A; Hajjar KA; Stainier DY; Chen EI; Lyden D; Bissell MJ
Nat Cell Biol; 2013 Jul; 15(7):807-17. PubMed ID: 23728425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
